178 related articles for article (PubMed ID: 8289993)
1. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries.
Kawamura T; Yoshioka T; Bills T; Fogo A; Ichikawa I
Kidney Int; 1991 Aug; 40(2):291-301. PubMed ID: 1942778
[TBL] [Abstract][Full Text] [Related]
3. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
Kokui K; Yoshikawa N; Nakamura H; Itoh H
J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
[TBL] [Abstract][Full Text] [Related]
5. Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms.
Hattori T; Ito M; Suzuki Y
Jpn J Pharmacol; 1991 Aug; 56(4):465-73. PubMed ID: 1744988
[TBL] [Abstract][Full Text] [Related]
6. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Ebihara I; Nakamura T; Tomino Y; Koide H
Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
[TBL] [Abstract][Full Text] [Related]
7. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
Kojima K; Matsui K; Nagase M
Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
[TBL] [Abstract][Full Text] [Related]
8. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
9. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
Higuchi A
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
11. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
Ricardo SD; Bertram JF; Ryan GB
J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
[TBL] [Abstract][Full Text] [Related]
12. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
Garin EH; Boggs KP; Burke FC
Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
[TBL] [Abstract][Full Text] [Related]
14. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
[TBL] [Abstract][Full Text] [Related]
15. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
16. Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats.
Shinosaki T; Takagawa I; Sunagawa N; Yonetani Y; Kurihara H
Jpn J Pharmacol; 1997 Apr; 73(4):337-45. PubMed ID: 9165371
[TBL] [Abstract][Full Text] [Related]
17. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury.
Kim YH; Goyal M; Wharram B; Wiggins J; Kershaw D; Wiggins R
Nephron; 2002 Apr; 90(4):471-6. PubMed ID: 11961407
[TBL] [Abstract][Full Text] [Related]
18. Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats.
Shibouta Y; Terashita Z; Imura Y; Shino A; Kawamura M; Ohtsuki K; Ohkawa S; Nishikawa K; Fujiwara Y
Kidney Int; 1991 May; 39(5):920-9. PubMed ID: 2067208
[TBL] [Abstract][Full Text] [Related]
19. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H
Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567
[TBL] [Abstract][Full Text] [Related]
20. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
